Schizophrenia News and Research

Latest Schizophrenia News and Research

Research: People's frontal cortex undergoes a significant change from infancy to adolescence

Experience of parents with their children and teachers with their students demonstrate how kids change their behaviours and knowledge from infancy to adolescence. Until now, little was known of the causes that could lead to these changes.

5 Jul 2013

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law - one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Study finds that long-term cannabis use affects motivation

Long-term cannabis users tend to produce less dopamine, a chemical in the brain linked to motivation, a study has found.

2 Jul 2013

Cannabis users appear to lack motivation

Researchers found that dopamine levels in a part of the brain called the striatum were lower in people who smoke more cannabis and those who began taking the drug at a younger age.

2 Jul 2013

Researchers find new treatment option for schizophrenia

A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine system in the brain.

1 Jul 2013

RUCDR Infinite Biologics receives $44.5 million Cooperative Agreement award from NIMH centre

RUCDR Infinite Biologics, the world's largest university-based biorepository, received a $44.5 million Cooperative Agreement award from the National Institute of Mental Health earlier this month to support its NIMH Center for Collaborative Genomics Research on Mental Disorders, which provides services to NIMH-funded scientists engaged in genomic research on mental disorders.

28 Jun 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists.

25 Jun 2013

TSRI neuroscientists fill in significant gap in the understanding of how neurons mature

Neuroscientists at The Scripps Research Institute have filled in a significant gap in the scientific understanding of how neurons mature, pointing to a better understanding of some developmental brain disorders.

21 Jun 2013

Duke Medicine researchers identify molecular target to prevent onset of epilepsy

Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.

21 Jun 2013

Targeted mental workouts can sharpen memory, improve cognitive function in schizophrenia

Much like physical exercise can re-chisel the body, researchers hope targeted mental workouts can sharpen the memory, focus and function of adults with schizophrenia.

20 Jun 2013

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.

19 Jun 2013

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

19 Jun 2013

Scientists find that psychiatric disorders may be linked to protein involved in memory formation

Researchers have discovered a pathway by which the brain controls a molecule critical to forming long-term memories and connected with bipolar disorder and schizophrenia.

17 Jun 2013

TAU researcher develops peptide to protect and restore microtubule function

A structure called "the microtubule network" is a crucial part of our nervous system. It acts as a transportation system within nerve cells, carrying essential proteins and enabling cell-to-cell communications. But in neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, this network breaks down, hindering motor abilities and cognitive function.

14 Jun 2013

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Ten scientists were named Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts today. The fellowship provides support to advance grantees' research, enables them to study with prominent U.S. scientists, and invests seed capital to help them establish laboratories in their home countries.

14 Jun 2013

Research: Sleep mechanism enables brain to consolidate emotional memory

Sleep researchers from University of California campuses in Riverside and San Diego have identified the sleep mechanism that enables the brain to consolidate emotional memory and found that a popular prescription sleep aid heightens the recollection of and response to negative memories.

13 Jun 2013

PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

There is growing evidence that a gene variant that reduces the plasticity of the nervous system also modulates responses to treatments for mood and anxiety disorders. In this case, patients with posttraumatic stress disorder, or PTSD, with a less functional variant of the gene coding for brain-derived neurotrophic factor, responded less well to exposure therapy.

13 Jun 2013

Columbia psychiatry researchers suggest possible approaches to treat or prevent OCD

Columbia Psychiatry researchers have identified what they think may be a mechanism underlying the development of compulsive behaviors. The finding suggests possible approaches to treating or preventing certain characteristics of OCD.

11 Jun 2013

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

Eve Marder, PhD, a professor of neuroscience at Brandeis University, is the recipient of the 2013 Neuroscience Prize of The Gruber Foundation. Marder is being honored with this prestigious international award for her pioneering contributions to the understanding of neural circuits, particularly how the properties and dynamics of neural circuits give rise to specific behaviors.

11 Jun 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Research: People's frontal cortex undergoes a significant change from infancy to adolescence

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Study finds that long-term cannabis use affects motivation

Cannabis users appear to lack motivation

Researchers find new treatment option for schizophrenia

RUCDR Infinite Biologics receives $44.5 million Cooperative Agreement award from NIMH centre

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

TSRI neuroscientists fill in significant gap in the understanding of how neurons mature

Duke Medicine researchers identify molecular target to prevent onset of epilepsy

Targeted mental workouts can sharpen memory, improve cognitive function in schizophrenia

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

Scientists find that psychiatric disorders may be linked to protein involved in memory formation

TAU researcher develops peptide to protect and restore microtubule function

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Research: Sleep mechanism enables brain to consolidate emotional memory

PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

Columbia psychiatry researchers suggest possible approaches to treat or prevent OCD

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in